Pressure Biosciences Probability of Future OTC Stock Price Finishing Over 0.4851
| PBIODelisted Stock | USD 0.49 0.00 0.00% |
Pressure |
Pressure Biosciences Target Price Odds to finish over 0.4851
The tendency of Pressure OTC Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.49 | 90 days | 0.49 | close to 99 |
Based on a normal probability distribution, the odds of Pressure Biosciences to move above the current price in 90 days from now is close to 99 (This Pressure Biosciences probability density function shows the probability of Pressure OTC Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Pressure Biosciences has a beta of -0.54 indicating as returns on the benchmark increase, returns on holding Pressure Biosciences are expected to decrease at a much lower rate. During a bear market, however, Pressure Biosciences is likely to outperform the market. Additionally Pressure Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Pressure Biosciences Price Density |
| Price |
Predictive Modules for Pressure Biosciences
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pressure Biosciences. Regardless of method or technology, however, to accurately forecast the otc stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the otc stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Pressure Biosciences Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Pressure Biosciences is not an exception. The market had few large corrections towards the Pressure Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Pressure Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Pressure Biosciences within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.86 | |
β | Beta against Dow Jones | -0.54 | |
σ | Overall volatility | 0.14 | |
Ir | Information ratio | -0.17 |
Pressure Biosciences Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Pressure Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Pressure Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Pressure Biosciences is not yet fully synchronised with the market data | |
| Pressure Biosciences has some characteristics of a very speculative penny stock | |
| Pressure Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Pressure Biosciences currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 2.04, implying the company greatly relies on financing operations through barrowing. Pressure Biosciences has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Pressure Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Pressure Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pressure Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pressure to invest in growth at high rates of return. When we think about Pressure Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2 M. Net Loss for the year was (20.15 M) with profit before overhead, payroll, taxes, and interest of 1.06 M. | |
| Pressure Biosciences currently holds about 121.57 K in cash with (4.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Pressure Biosciences Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Pressure OTC Stock often depends not only on the future outlook of the current and potential Pressure Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pressure Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 9.1 M |
Pressure Biosciences Technical Analysis
Pressure Biosciences' future price can be derived by breaking down and analyzing its technical indicators over time. Pressure OTC Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Pressure Biosciences. In general, you should focus on analyzing Pressure OTC Stock price patterns and their correlations with different microeconomic environments and drivers.
Pressure Biosciences Predictive Forecast Models
Pressure Biosciences' time-series forecasting models is one of many Pressure Biosciences' otc stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Pressure Biosciences' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the otc stock market movement and maximize returns from investment trading.
Things to note about Pressure Biosciences
Checking the ongoing alerts about Pressure Biosciences for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Pressure Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Pressure Biosciences is not yet fully synchronised with the market data | |
| Pressure Biosciences has some characteristics of a very speculative penny stock | |
| Pressure Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Pressure Biosciences currently holds 150 K in liabilities with Debt to Equity (D/E) ratio of 2.04, implying the company greatly relies on financing operations through barrowing. Pressure Biosciences has a current ratio of 0.07, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Pressure Biosciences until it has trouble settling it off, either with new capital or with free cash flow. So, Pressure Biosciences' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Pressure Biosciences sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Pressure to invest in growth at high rates of return. When we think about Pressure Biosciences' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 2 M. Net Loss for the year was (20.15 M) with profit before overhead, payroll, taxes, and interest of 1.06 M. | |
| Pressure Biosciences currently holds about 121.57 K in cash with (4.87 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01. |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Pressure OTC Stock
If you are still planning to invest in Pressure Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pressure Biosciences' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Stocks Directory Find actively traded stocks across global markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |